Bo-Ya Liu Selected Research

AGRO 100

4/2020	Aptamer/Peptide-Functionalized Genome-Editing System for Effective Immune Restoration through Reversal of PD-L1-Mediated Cancer Immunosuppression.
1/2020	Facile Strategy To Enhance Specificity and Sensitivity of Molecular Beacons by an Aptamer-Functionalized Delivery Vector.
7/2019	Peptide and Aptamer Decorated Delivery System for Targeting Delivery of Cas9/sgRNA Plasmid To Mediate Antitumor Genome Editing.
12/2018	Tumor targeted genome editing mediated by a multi-functional gene vector for regulating cell behaviors.
12/2018	Reversal of tumor malignization and modulation of cell behaviors through genome editing mediated by a multi-functional nanovector.
11/2018	Aptamer-functionalized albumin-based nanoparticles for targeted drug delivery.
1/2018	A Dual-Targeting Delivery System for Effective Genome Editing and In Situ Detecting Related Protein Expression in Edited Cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Bo-Ya Liu Research Topics

Disease

14	Neoplasms (Cancer) 11/2020 - 01/2015
4	Neoplasm Metastasis (Metastasis) 01/2019 - 11/2018
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2015
1	Hemorrhage 06/2013
1	Pulmonary Edema 06/2013
1	Acute Lung Injury 06/2013

Drug/Important Bio-Agent (IBA)

7	AGRO 100IBA 04/2020 - 01/2018
5	Proteins (Proteins, Gene)FDA Link 04/2020 - 01/2018
4	NucleolinIBA 11/2020 - 12/2018
4	Peptides (Polypeptides)IBA 11/2020 - 06/2017
4	VimentinIBA 07/2019 - 11/2018
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 07/2019 - 01/2018
3	Hyaluronic Acid (Hyaluronan)IBA 11/2020 - 08/2018
3	Cadherins (E-Cadherin)IBA 07/2019 - 11/2018
3	PolymersIBA 12/2018 - 01/2017
2	CateninsIBA 04/2020 - 01/2019
2	SurvivinIBA 01/2020 - 01/2018
2	carboxymethyl-chitosanIBA 01/2020 - 06/2017
2	Protamines (Protamine Sulfate)FDA Link 01/2020 - 08/2018
2	Focal Adhesion Protein-Tyrosine KinasesIBA 07/2019 - 12/2018
2	Matrix Metalloproteinases (MMPs)IBA 07/2019 - 12/2018
2	micaIBA 12/2018 - 12/2018
2	LigandsIBA 12/2018 - 01/2018
2	CytokinesIBA 08/2018 - 01/2017
2	Biotin (Vitamin H)FDA Link 01/2018 - 06/2017
1	Histones (Histone)IBA 11/2020
1	B7-H1 AntigenIBA 04/2020
1	Messenger RNA (mRNA)IBA 01/2020
1	Atrial Natriuretic Factor (ANF)IBA 01/2020
1	Focal Adhesion Kinase 1IBA 07/2019
1	Protein Sorting Signals (Signal Peptide)IBA 07/2019
1	Tumor Suppressor Protein p53IBA 12/2018
1	Mucin-1 (CA 15-3 Antigen)IBA 12/2018
1	Doxorubicin (Adriamycin)FDA LinkGeneric 11/2018
1	Epithelial Cell Adhesion MoleculeIBA 11/2018
1	AlbuminsIBA 11/2018
1	Bovine Serum AlbuminIBA 11/2018
1	Fc Receptors (Fc Receptor)IBA 08/2018
1	DNA (Deoxyribonucleic Acid)IBA 08/2018
1	Neuropilin-1IBA 08/2018
1	TuftsinIBA 08/2018
1	Interleukin-12 (IL 12)IBA 08/2018
1	Fas Ligand Protein (Fas Ligand)IBA 12/2017
1	OligodeoxyribonucleotidesIBA 12/2017
1	CaspasesIBA 12/2017
1	AvidinIBA 06/2017
1	Interleukin-10 (Interleukin 10)IBA 01/2017
1	ATP-Binding Cassette Transporters (ABC Transporters)IBA 01/2015
1	Cisplatin (Platino)FDA LinkGeneric 01/2015
1	Adenosine Triphosphate (ATP)IBA 01/2015
1	LipopolysaccharidesIBA 06/2013
1	shikoninIBA 06/2013
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 06/2013
1	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 06/2013

Therapy/Procedure

2	Therapeutics 04/2020 - 11/2018
1	Immunotherapy 08/2018
1	Drug Therapy (Chemotherapy) 01/2015